BioHorizons Announces Agreement to Purchase Implant Log... ( BIRMINGHAM Ala. and CEDARHURST N....)

BioHorizons Announces Agreement to Purchase Implant Logic Systems

Date:1/30/2008

BIRMINGHAM, Ala., and CEDARHURST, N.Y., Jan 30 /PRNewswire/ -- BioHorizons Implant Systems, Inc. ("BioHorizons") announced today its parent company has entered into a definitive agreement to purchase Implant Logic Systems, Ltd. ("ILS"). ILS is a leading innovator and provider of technology solutions for the implant dentistry market. ILS's Virtual Implant Placement software enables implantologists to view CT scans and create virtual implant treatment plans. Implantologists can then use ILS's Compu-Guide system to create custom milled surgical guides that bring the virtual treatment plan into the operating suite. Terms of the transaction were not disclosed.

"We are thrilled to add the technology and expertise of ILS to BioHorizons," stated R. Steven Boggan, President and CEO of BioHorizons. "Our customers have expressed great interest in computer assisted implant treatment planning software and surgical guides. ILS perfectly addresses this customer need. In addition, the Compu-Guide surgical guide system is designed to allow the clinician to place implants more accurately, more quickly and more safely than is otherwise possible. The acquisition of ILS will create significant value for our customers."

Dr. Michael Klein, President and CEO of ILS, stated, "We are excited about the opportunity to join with BioHorizons. ILS is already well known for its implant planning software and innovative computer guided surgical tools, but our customers will now get the expanded benefits of working with BioHorizons, one of the most progressive and customer-centric companies in the industry."

For More Information:

Steve Boggan

President and CEO of BioHorizons

205.967.7880

About Implant Logic Systems

Implant Logic Systems is leading the dental implant market with innovative, technologically advanced, surgical tools which significantly improve implant placement quality and accessibility for both doctors and patients. Impl
'/>"/>

0

GOOD

Page: 1 2
Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results

Post Your Comments:

BioHorizons Announces Agreement to Purchase Implant Log...( BIRMINGHAM Ala. and CEDARHURST N....)